| abstract |
The invention relates to the pharmaceutical industry in general and to the pharmaceutical industry involved in the production of various different sublingual solid pharmaceutical formulations containing meloxicam. The inventive pharmaceutical formulations are characterized in that they comprise: (a) meloxicam, (b) one or more anti-adherents, (c) one or more disintegrating agents, (d) one or more binding agents, (e) one or more lubricants, (f) one or more diluent agents, (g) one or more solvents, (h) one or more solubilising agents, (i) one or more sweetening agents, (j) one or more flavouring agents and/or essences, (k) one or more viscosity agents, (1) one or more antimicrobial agents, (m) one or more surfactants, (n) one or more antioxidants, (o) one or more emulsifying agents, and (p) any other additive that helps the formulation. |